Sign In
17 Nov 2015 10:29
ο»Ώ
Β
Β FORM 38.5(a)
Β
IRISHΒ TAKEOVERΒ PANEL
Β
DISCLOSUREΒ UNDERΒ RULEΒ 38.5(a)Β OFΒ THEΒ IRISHΒ TAKEOVERΒ PANELΒ ACT,Β 1997, TAKEOVER Β RULES,Β 2013
Β
DEALINGS BY CONNECTEDΒ EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARYΒ STATUS AND DEALING IN A CLIENT-SERVING CAPACITY
Β
Β
1. KEYΒ INFORMATION
Β Name of exempt market-maker | Morgan Stanley Capital Services LLC |
Β Company dealt in | PFIZER INC |
Β Class of relevant security to which the dealings being disclosed relate (Note 1) | US$0.05 COMMON STOCK |
Β Date of dealing | 16 NOVEMBER 2015 |
Β
Β
2. DEALINGSΒ (NoteΒ 2)
Β
(a) PurchasesΒ andΒ sales
Β Total number of relevant secuities accquired | Β Highest price paid (Note 3) | Β Lowest price paid (Note 3) |
Β Β 535,288 | Β 33.3900 USD | Β 32.8500 USD |
Β
Β Total number of relevant secuities disposed | Β Highest price paid (Note 3) | Β Lowest price paid (Note 3) |
Β Β 258,728 | Β 33.4000 USD | Β 32.8550 USD |
Β
Β
(b) DerivativesΒ transactionsΒ (otherΒ thanΒ optionsΒ transactions)
Β
Β Product name, e.g. CFD | Β Nature of transaction (Note 4) | Β Number of relevant securities (Note 5) | Β Price per unit |
Β CFD | Β LONG | Β 240 | Β 32.9731 USD |
Β CFD | Β LONG | Β 3,200 | Β 32.9787 USD |
Β CFD | Β LONG | Β 1,350 | Β 33.0010 USD |
Β CFD | Β LONG | Β 90 | Β 33.0010 USD |
Β CFD | Β LONG | Β 286 | Β 33.0010 USD |
Β CFD | Β LONG | Β 11 | Β 33.0010 USD |
Β CFD | Β LONG | Β 7 | Β 33.0010 USD |
Β CFD | Β LONG | Β 93,338 | Β 33.0167 USD |
Β CFD | Β LONG | Β 147 | Β 33.0230 USD |
Β CFD | Β LONG | Β 62 | Β 33.0230 USD |
Β CFD | Β LONG | Β 4,300 | Β 33.0274 USD |
Β CFD | Β LONG | Β 2,000 | Β 33.0359 USD |
Β CFD | Β LONG | Β 8,500 | Β 33.0369 USD |
Β CFD | Β LONG | Β 80,348 | Β 33.0684 USD |
Β CFD | Β LONG | Β 36,837 | Β 33.0700 USD |
Β CFD | Β LONG | Β 400 | Β 33.0700 USD |
Β CFD | Β LONG | Β 1,400 | Β 33.0814 USD |
Β CFD | Β LONG | Β 14,500 | Β 33.0874 USD |
Β CFD | Β LONG | Β 100 | Β 33.0950 USD |
Β CFD | Β LONG | Β 100 | Β 33.0950 USD |
Β CFD | Β LONG | Β 6 | Β 33.0969 USD |
Β CFD | Β LONG | Β 71 | Β 33.0990 USD |
Β CFD | Β LONG | Β 143 | Β 33.0990 USD |
Β CFD | Β LONG | Β 94 | Β 33.1007 USD |
Β CFD | Β LONG | Β 9 | Β 33.1007 USD |
Β CFD | Β LONG | Β 200 | Β 33.1600 USD |
Β CFD | Β LONG | Β 100 | Β 33.2000 USD |
Β CFD | Β LONG | Β 9,190 | Β 33.2727 USD |
Β CFD | Β LONG | Β 500 | Β 33.2773 USD |
Β CFD | Β SHORT | Β 200 | Β 32.9400 USD |
Β CFD | Β SHORT | Β 8,900 | Β 32.9467 USD |
Β CFD | Β SHORT | Β 420 | Β 32.9493 USD |
Β CFD | Β SHORT | Β 231 | Β 32.9524 USD |
Β CFD | Β SHORT | Β 2,600 | Β 32.9542 USD |
Β CFD | Β SHORT | Β 4,032 | Β 32.9549 USD |
Β CFD | Β SHORT | Β 270 | Β 32.9549 USD |
Β CFD | Β SHORT | Β 31 | Β 32.9549 USD |
Β CFD | Β SHORT | Β 854 | Β 32.9549 USD |
Β CFD | Β SHORT | Β 19 | Β 32.9549 USD |
Β CFD | Β SHORT | Β 21 | Β 32.9600 USD |
Β CFD | Β SHORT | Β 56 | Β 32.9665 USD |
Β CFD | Β SHORT | Β 8,700 | Β 32.9681 USD |
Β CFD | Β SHORT | Β 18,867 | Β 32.9747 USD |
Β CFD | Β SHORT | Β 6,800 | Β 33.0021 USD |
Β CFD | Β SHORT | Β 51,700 | Β 33.0125 USD |
Β CFD | Β SHORT | Β 3,900 | Β 33.0253 USD |
Β CFD | Β SHORT | Β 5,200 | Β 33.0435 USD |
Β CFD | Β SHORT | Β 151,000 | Β 33.0499 USD |
Β CFD | Β SHORT | Β 1,637 | Β 33.0508 USD |
Β CFD | Β SHORT | Β 24,465 | Β 33.0508 USD |
Β CFD | Β SHORT | Β 116 | Β 33.0508 USD |
Β CFD | Β SHORT | Β 5,184 | Β 33.0508 USD |
Β CFD | Β SHORT | Β 194 | Β 33.0508 USD |
Β CFD | Β SHORT | Β 226 | Β 33.0525 USD |
Β CFD | Β SHORT | Β 544 | Β 33.0525 USD |
Β CFD | Β SHORT | Β 1,698 | Β 33.0763 USD |
Β CFD | Β SHORT | Β 90,400 | Β 33.0779 USD |
Β CFD | Β SHORT | Β 400 | Β 33.0825 USD |
Β CFD | Β SHORT | Β 200 | Β 33.0950 USD |
Β CFD | Β SHORT | Β 7,500 | Β 33.0993 USD |
Β CFD | Β SHORT | Β 10,492 | Β 33.1009 USD |
Β CFD | Β SHORT | Β 100 | Β 33.1100 USD |
Β CFD | Β SHORT | Β 100 | Β 33.1400 USD |
Β CFD | Β SHORT | Β 1,000 | Β 33.1509 USD |
Β CFD | Β SHORT | Β 567 | Β 33.1600 USD |
Β CFD | Β SHORT | Β 36,900 | Β 33.2658 USD |
Β CFD | Β SHORT | Β 3,333 | Β 33.3145 USD |
Β
Β
(c) OptionsΒ transactionsΒ inΒ respectΒ ofΒ existingΒ relevantΒ securities
Β
i) Writing,Β selling,Β purchasingΒ orΒ varying
Β
Β Product name, eg call option | Β Writing, selling, purchasing, varying etc | Β Number of securities to which the option relates (Note 5) | Β Exercise Price | Β Type, e.g American, European etc | Β Expiry Date | Β Option money paid/received per unit (Note 3) |
Β N/A | Β N/A | Β N/A | Β N/A | Β N/A | Β N/A | Β N/A |
Β
(ii) Exercising
Β
Β Product name, eg call option | Β Number of securities | Β Exercise price per unit (Note 3) |
Β N/A | Β N/A | Β N/A |
Β
Β
3. OTHER INFORMATION
Β
Agreements, arrangements or understandings relating to options or derivatives
Β
Full Details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. Β |
Β Β Β Β Β |
Β
Β
Β Date of disclosure | 17 NOVEMBER 2015 |
Β Contact Name | Craig Horsley |
Β Telephone Number | +44(141) 245 7736 |
Β Name of offeree/offeror with which connected | ALLERGAN PLC |
Nature of connection (Note 6) | Advisory |
Β
Follow the stocks
